From AI validation to microstructure imaging, AAPS PharmSci 360 speakers pushed toward faster drug development backed by stronger evidence. Here are PharmTech's biggest takeaways.
The series C raise, co-led by Johnson & Johnson’s venture capital arm, will help Delix Therapeutics push its novel ...
Compass Pathways (NASDAQ:CMPS) could secure US regulatory approval for its experimental depression treatment COMP360 as early as December or January, Jefferies has forecast. The broker's assessment ...
Johnson & Johnson led a $100M investment in a psychedelic-inspired biotech, signaling strategic interest in neuroscience ...
Experts share the habits and triggers to avoid, plus the remedies that could help alleviate a persistent hack following a ...
The FDA granted accelerated approval to Rybrevant Faspro for recurrent or metastatic head and neck cancer that grew after ...
"FDA expands J&J's Rybrevant Faspro label with head and neck cancer approval" was originally created and published by Pharmaceutical Technology, a GlobalData owned brand. President Trump says he will ...
Johnson & Johnson (NYSE: JNJ) today announced that the U.S. Food and Drug Administration (FDA) granted accelerated approval ...
Johnson & Johnson (NYSE: JNJ) today announced that the U.S. Food and Drug Administration (FDA) granted accelerated approval ...
The FDA granted accelerated approval for amivantamab and hyaluronidase-lpuj for recurrent or metastatic head and neck cancer ...
The US Food and Drug Administration on Thursday granted accelerated approval to Johnson & Johnson's treatment for patients ...